KR940000320B1 - Method of making food containing of nokaren - Google Patents
Method of making food containing of nokaren Download PDFInfo
- Publication number
- KR940000320B1 KR940000320B1 KR1019910013064A KR910013064A KR940000320B1 KR 940000320 B1 KR940000320 B1 KR 940000320B1 KR 1019910013064 A KR1019910013064 A KR 1019910013064A KR 910013064 A KR910013064 A KR 910013064A KR 940000320 B1 KR940000320 B1 KR 940000320B1
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- blood
- deer blood
- squalene
- weight
- Prior art date
Links
- 238000004519 manufacturing process Methods 0.000 title description 4
- 235000013305 food Nutrition 0.000 title description 3
- 210000004369 blood Anatomy 0.000 claims abstract description 34
- 239000008280 blood Substances 0.000 claims abstract description 34
- 239000000843 powder Substances 0.000 claims abstract description 27
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 claims abstract description 12
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 claims abstract description 12
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229940031439 squalene Drugs 0.000 claims abstract description 12
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 claims abstract description 8
- 235000003140 Panax quinquefolius Nutrition 0.000 claims abstract description 8
- 235000008434 ginseng Nutrition 0.000 claims abstract description 8
- 239000007901 soft capsule Substances 0.000 claims abstract description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 6
- 235000013402 health food Nutrition 0.000 claims abstract description 6
- 235000012907 honey Nutrition 0.000 claims abstract description 6
- 235000019482 Palm oil Nutrition 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 5
- 239000002540 palm oil Substances 0.000 claims abstract description 5
- 239000011732 tocopherol Substances 0.000 claims abstract description 4
- 229930003799 tocopherol Natural products 0.000 claims abstract description 4
- 229960001295 tocopherol Drugs 0.000 claims abstract description 4
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 4
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 4
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 claims abstract description 3
- 239000007902 hard capsule Substances 0.000 claims abstract description 3
- 235000010445 lecithin Nutrition 0.000 claims abstract description 3
- 239000000787 lecithin Substances 0.000 claims abstract description 3
- 229940067606 lecithin Drugs 0.000 claims abstract description 3
- 239000006187 pill Substances 0.000 claims abstract description 3
- 229930003231 vitamin Natural products 0.000 claims abstract description 3
- 235000013343 vitamin Nutrition 0.000 claims abstract description 3
- 239000011782 vitamin Substances 0.000 claims abstract description 3
- 229940088594 vitamin Drugs 0.000 claims abstract description 3
- 244000068988 Glycine max Species 0.000 claims abstract 2
- 235000010469 Glycine max Nutrition 0.000 claims abstract 2
- 150000003904 phospholipids Chemical class 0.000 claims abstract 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims abstract 2
- 239000008158 vegetable oil Substances 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 8
- 239000004615 ingredient Substances 0.000 claims description 4
- 240000008397 Ganoderma lucidum Species 0.000 claims description 3
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 3
- 244000131316 Panax pseudoginseng Species 0.000 claims 1
- 241000282994 Cervidae Species 0.000 abstract description 8
- 241000208340 Araliaceae Species 0.000 abstract description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 5
- 238000002156 mixing Methods 0.000 abstract description 4
- 239000000654 additive Substances 0.000 abstract 1
- 239000012467 final product Substances 0.000 abstract 1
- 238000012856 packing Methods 0.000 abstract 1
- 150000003722 vitamin derivatives Chemical class 0.000 abstract 1
- 238000003860 storage Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 6
- 239000002994 raw material Substances 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 3
- 239000002075 main ingredient Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 235000019155 vitamin A Nutrition 0.000 description 3
- 239000011719 vitamin A Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 210000003056 antler Anatomy 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- 230000007368 endocrine function Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229960000443 hydrochloric acid Drugs 0.000 description 2
- 235000011167 hydrochloric acid Nutrition 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007774 longterm Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 230000007103 stamina Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QDGAVODICPCDMU-UHFFFAOYSA-N 2-amino-3-[3-[bis(2-chloroethyl)amino]phenyl]propanoic acid Chemical compound OC(=O)C(N)CC1=CC=CC(N(CCCl)CCCl)=C1 QDGAVODICPCDMU-UHFFFAOYSA-N 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 229930182844 L-isoleucine Natural products 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 241000209140 Triticum Species 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Chemical group 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960003767 alanine Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical group OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 1
- 235000000639 cyanocobalamin Nutrition 0.000 description 1
- 239000011666 cyanocobalamin Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- PXEDJBXQKAGXNJ-QTNFYWBSSA-L disodium L-glutamate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CCC([O-])=O PXEDJBXQKAGXNJ-QTNFYWBSSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000020710 ginseng extract Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 244000038280 herbivores Species 0.000 description 1
- 244000144980 herd Species 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 208000028867 ischemia Diseases 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- -1 licorice extract Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 230000004220 muscle function Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 230000007420 reactivation Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000010686 shark liver oil Substances 0.000 description 1
- 229940069764 shark liver oil Drugs 0.000 description 1
- 229940073490 sodium glutamate Drugs 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- BPJYAXCTOHRFDQ-UHFFFAOYSA-L tetracopper;2,4,6-trioxido-1,3,5,2,4,6-trioxatriarsinane;diacetate Chemical compound [Cu+2].[Cu+2].[Cu+2].[Cu+2].CC([O-])=O.CC([O-])=O.[O-][As]1O[As]([O-])O[As]([O-])O1.[O-][As]1O[As]([O-])O[As]([O-])O1 BPJYAXCTOHRFDQ-UHFFFAOYSA-L 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Chemical group 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000010497 wheat germ oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/12—Animal proteins from blood
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/20—Agglomerating; Granulating; Tabletting
- A23P10/28—Tabletting; Making food bars by compression of a dry powdered mixture
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Mycology (AREA)
- Biochemistry (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
본 발명은 녹혈을 주성분으로 함유하는 건강식품의 제조방법에 관한 것이다.The present invention relates to a method for producing a health food containing rusted blood as a main component.
사슴은 고산의 산림지대와 초원에서 무리를 이루어 군서생활을 하는 초식동물로 녹용이나 녹혈등은 인삼과 함께 영약으로 사용되어 왔다. 동의보감 및 동의학 사전에 의하여 녹혈은 허를 보하고 요통과 폐위(폐기능저하)·신체허약·허혈·심계항진·불면증·자궁출혈 및 음위증등에 효과가 좋다고 기술되어 있다.Deer is a herbivore that lives in herds in high mountain forests and grasslands. Deer antler and green blood have been used as ginseng along with ginseng. Consequences of consent and synonym have been shown to be effective for low back pain, lung pain (lower lung function), physical weakness, ischemia, palpitations, insomnia, uterine bleeding, and vulgaris.
지금까지 녹혈은 대부분 사슴으로부터 녹용을 채취할때 나오는 녹혈을 그대로 섭취하여 왔다. 이러한 녹혈의 섭취는 비위생적일 뿐만 아니라, 녹혈을 저장할 수 없는 문제점이 있었다. 또한 녹혈을 분말화하여 복용하기 위한 시도가 있었으나 종래의 제법에 의한 녹혈분말은 흡습성이 강하고 또한 장기간 보관시 변패가 쉽게 일어나는 문제가 있었다.Until now, most of the green blood has been taken from the green blood from the deer antler. Ingestion of such congestive blood is not only unsanitary, but there is a problem that can not be stored. In addition, attempts have been made to powder green blood, but the green blood powder according to the conventional manufacturing method has a strong hygroscopicity, and there is a problem in that decay occurs easily during long-term storage.
본 발명자들은 녹혈을 살균처리하여 냉동건조시켜 녹혈분말을 제조하는 새로운 방법을 개발하였다. 이 방법은 채취된 녹혈에 에탄올을 가하여 살균처리 및 응고를 방지한 후 동결건조기에 넣어 동결건조시키고 다시 외부온도를 40℃ 내지 50℃로 상승시켜 건조시키는 방법이다. 이 방법에 의하여 제조된 녹혈분말은 다음의 조성을 가지고 있다.The present inventors have developed a new method for preparing rust blood powder by sterilizing rust blood and freeze drying. In this method, ethanol is added to the collected green blood to prevent sterilization and coagulation, and then lyophilized in a lyophilizer and dried by raising the external temperature to 40 ° C to 50 ° C. The green blood powder prepared by this method has the following composition.
녹혈에는 아직까지 밝혀지지 않은 약효성분이 더 많이 있을 것으로 사료되며, 특히 셀레니움이 다량 함유되어 있어 항암등의 효능도 있는 것으로 사료된다.It is thought that there are more medicinal ingredients that have not been identified yet, and especially selenium contains a large amount of anti-cancer effects.
그러나 종래부터 지금까지 녹혈분말을 복용하기 위하여는 분말상 그대로 복용하여야만 하는 불편이 여전히 있었다. 더구나 본원 발명에 사용되는 녹혈분말 역시 흡습성이 대단히 크고 변질되기 쉽기 때문에 그대로 상품화되는 데에는 큰 문제점이 있다.However, in order to take the green blood powder conventionally until now, there was still the inconvenience that must be taken as it is in powder form. In addition, since the hygroscopicity used in the present invention is very hygroscopic and easily deteriorated, there is a big problem in commercializing it as it is.
따라서 본 발명자는 오랜동안 연구한 결과 녹혈분말과 스쿠알렌을 복합제조하여 연질캡슐제제로 하면, 영양면에서도 균형있는 건강 보조식품이 될뿐만 아니라, 성분자체가 안정화되어 유통에도 극히 편리하게 되고 또한 본 발명의 제품을 장기간 투여하는 경우 혈중지질 수준을 조절하고 운동시 유출되는 혈중 효소의 유출을 억제하는 등의 사실을 발견하여 본 발명을 완성하게 되었다.Therefore, the present inventors have studied for a long time as a soft capsule formulation by producing a combination of green blood powder and squalene, not only become a balanced dietary supplement in terms of nutrition, but also stabilizes the ingredients themselves and is extremely convenient for distribution. In the case of long-term administration of the product, the present inventors have discovered the fact of controlling blood lipid levels and inhibiting the outflow of blood enzymes during exercise.
따라서 본 발명의 목적은 녹혈분말과 스쿠알렌을 주성분으로 함유하는 건강식품을 제공하는 것이다.Therefore, it is an object of the present invention to provide a health food containing rust blood powder and squalene as a main ingredient.
이하 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 녹혈분말과 스쿠알렌을 주성분으로 하여 적절한 비율로 혼합하고 여기에 기타 여러가지 건강식품의 성분, 예를들면 토코페롤, 상어간유, 팜유, 라노린, 레시틴, 영지엑기스등을 첨가하여 제제화한다. 제제의 형태는슐, 환, 정제 또는 파우다로 할 수 있다. 녹혈분말에 스쿠알렌을 첨가하면 녹혈분말 자체의 저장 안정성이 좋아지고 또한 복용하기가 용이하다. 따라서 종래의 녹혈분말만으로 된 제품의 저장안정성을 개선했으며 복용시 분말이기 때문에 번거러웠던 점을 모두 해소하였다.The present invention is formulated by adding the oxidized blood powder and squalene as a main ingredient and mixing in an appropriate ratio, and ingredients of various other health foods, for example, tocopherol, shark liver oil, palm oil, lanolin, lecithin, and Ganoderma lucidum extract. The form of the formulation It can be done as a shool, pill, tablet or powder. The addition of squalene to the green blood powder improves the storage stability of the green blood powder itself and is easy to take. Therefore, the storage stability of the conventional products containing only rust blood powder was improved and all the troublesome points were eliminated because the powder was taken.
본 발명에서 사용하는 스쿠알렌은 심해상어의 간으로부터 추출한 에센스로 생체내에서 산소와 에너지를 생성할 뿐만 아니라, 비타민 A, D, E와 같은 영양소의 역할도 나타내는 신비로운 물질로서 산소공급을 원활하게 하여 체내 신진대사를 좋게함으로 체내정화작용을 하며, 허약체질인 사람들에서 면역성을 증강시켜서 저항력을 높여주며, 세포부활작용 및 노화방지, 피부미용에 좋은 효과를 나타내며, 벼와 근육의 고른 성장, 내분비 기능을 정상화시키는 비타민 A, D, E와 같은 작용으로 하며, 체내에서 산소와 에너지를 생성하므로서 스태미너 및 체력증진에 뛰어난 효과를 나타내며, 지방축적을 막아주고 내분비 기능을 정상화시켜주어 성인병질환이 있는 사람들에게는 식이요법제로서도 작용한다.Squalene used in the present invention is an essence extracted from the liver of a deep sea shark and not only generates oxygen and energy in vivo, but also shows a mysterious substance showing the role of nutrients such as vitamins A, D, and E. It enhances metabolism, improves body metabolism, enhances immunity in people with weak constitutions, enhances resistance, and has good effects on cell reactivation, anti-aging, skin beauty, even growth of rice and muscle, and endocrine function. It acts like vitamins A, D, and E to normalize. It produces oxygen and energy in the body, and has an excellent effect on stamina and stamina. It also prevents fat accumulation and normalizes endocrine function. It also acts as a therapy.
본 발명에서는 녹혈분말 3-50중량부와 스쿠알렌 50-90중량부를 함유한다. 녹혈분말의 양은 스쿠알렌 양보다 많이 첨가할 수도 있으나, 이와 같은 경우에는 녹혈분말의 함량이 증가하여 저장안정성이 영향을 주므로, 완전 밀봉해 주어야 하기 때문에 스쿠알렌 양보다 적게 첨가하는 것이 좋다.In the present invention, it contains 3-50 parts by weight of green blood powder and 50-90 parts by weight of squalene. The amount of green blood powder may be added more than the amount of squalene, but in this case, the content of the green blood powder increases, which affects the storage stability, so it is better to add less than the amount of squalene because it must be completely sealed.
본 발명에서는 상기 주성분 이외에 기타의 약효성분 예를들면 인삼엑기스, 영지엑기스, 감초엑기스와 같은 식물성 엑기스, 비타민 A, 비타민 B군, 비타민 C, 비타민 E, 염산, 염산, 피리독신, 시아노코발아민, 니코틴산아미드, 글루타민산소다 등과 같은 비타민류, 글라이신, 알라닌, L-이소류신, L-페닐알닌, L-라이산, 트립토판 등과 같은 아미노산류 등을 더 함유할 수도 있다.In the present invention, in addition to the main ingredient, other active ingredients such as ginseng extract, ganoderma lucidum extract, vegetable extracts such as licorice extract, vitamin A, vitamin B group, vitamin C, vitamin E, hydrochloric acid, hydrochloric acid, pyridoxine, cyanocobalamine, Vitamins such as nicotinamide, sodium glutamate, and the like, amino acids such as glycine, alanine, L-isoleucine, L-phenylalanine, L-lysic acid, tryptophan and the like may be further contained.
또한, 본 발명에서는 벌꿀, 로얄제리, 이성화당 등을 함유할 수도 있다.In the present invention, it may also contain honey, royal jelly, isomerized sugar and the like.
본 발명에서는 통상으로 연질캡슐의 제조에 사용되는 옥수수기름, 콩기름, 면실유, 채종유, 들깨유, 참깨유, 소맥배아유, 팜유등과 같은 식물유, 대두인지질(레시린), 모노 글리세라이드유 및 밀탑과 같은 납류를 함유할 수도 있다.In the present invention, corn oil, soybean oil, cottonseed oil, rapeseed oil, perilla oil, sesame oil, wheat germ oil, palm oil and the like, soybean phospholipid (lesirin), monoglyceride oil and wheat top, which are commonly used in the manufacture of soft capsules. It may also contain lead such as
본원 발명에 의해 제조한 제품을 건강한 운동선수 20명을 대상으로 4주간 복용시켜 실험한 결과 복용치 않은 그룹보다 다음과 같은 효과가 나타났다.The product prepared according to the present invention was tested for 20 healthy athletes for 4 weeks, and the results were as follows.
본원 발명의 제품을 복용한 쪽이 혈액의 효소 활성도 변화에서는 근육의 손상 및 과격한 운동시 세포막 투과성 변화로 나타나는 혈중효소의 유출등에 지표가 되는 효소가 본발명 제품의 복용으로 억제되는 경향이 나타났고, 심혈 관계의 성인병 유병율과 높은 상관을 가지고 있는 것으로 알려진 혈중지질 성분인 콜레스테롤이 안정적으로 유지되는 경향이 있었으며, 일반적인 혈액검사에서는 적혈구, 헤모글로빈과 헤마토크리트가 다소 증가하는 경향을 보였다. 또한 운동수행력 테스트에서는 작업능력, 최대파워, 피로도에서 본원 발명의 제품을 복용한 쪽이 향상되었으며 운동직후의 피로도와 비례하여 나타나는 젖산농도에서도 다소 감소하였다.In the case of taking the product of the present invention, in the change of enzyme activity of blood, enzymes, which are indicative of the damage of muscles and the outflow of blood enzymes, which appear as changes in cell membrane permeability during strenuous exercise, tended to be suppressed by taking the present invention. Cholesterol, a cholesterol component known to have a high correlation with the prevalence of cardiovascular disease, tended to be stable. In general blood tests, red blood cells, hemoglobin and hematocrit were slightly increased. In addition, the exercise performance test was improved in taking the product of the present invention in work capacity, maximum power, fatigue, and also slightly decreased in the lactic acid concentration which is proportional to the fatigue immediately after exercise.
캡슐기제로는 젤라틴과 글리세린을 적당량 혼합하여 사용하며 이들의 사용은 연질캡슐의 제조에서는 잘 알려진 공지방법이다. 또한 본 발명의 제품을 공지의 방법으로 경질캡슐로 제조할 수도 있다.As the capsule base, a proper amount of gelatin and glycerin are mixed and their use is well known in the preparation of soft capsules. In addition, the product of the present invention may be prepared as a hard capsule by a known method.
본 발명자들은 또한 녹혈분말 및 스쿠알렌에 인삼가루 및 꽃가루를 잘 섞은 다음 꿀을 첨가하여 환으로 만들경우 저장 안정성이 매우 좋다는 것을 알았다. 이 경우 녹혈분말을 60-80중량부 사용하는 것이 바람직하고, 인삼가루는 10-20중량부, 꽃가루 2-5중량부 결합제로서 꿀을 5-15중량부 사용하는 것이 좋다. 이때 저장 안정성을 높이기 위해 밀납 파라핀 왁스 등으로 완전히 싸 밀봉하는 것이 좋다.The inventors also found that storage stability is very good when the ginseng powder and squalene are mixed well with ginseng powder and pollen, and then honey is added to make the ring. In this case, it is preferable to use 60-80 parts by weight of green blood powder, and ginseng powder is 10-20 parts by weight, and 5-15 parts by weight of honey is used as a binder for 2-5 parts by weight of pollen. At this time, in order to increase the storage stability, it is good to seal completely with beeswax paraffin wax.
다음에 실시예로서 본 발명을 더욱 상세히 설명한다.Next, the present invention will be described in more detail by way of examples.
실시예에서 %는 모두 중량%이다.In the examples all% is by weight.
[실시예 1]Example 1
스쿠알렌과 녹혈, 팜유 및 토코페롤을 배합탱크에서 약 100RPM으로 약 30분간 혼합하고 혼합된 원료를 분쇄기에서 약 80℃의 온도에서 약 2500RPM으로 150-200멧쉬로 분쇄하고, 분쇄된 원료물질을 배합탱크로 이송하여 반복균질 분쇄하고 살균 처리한다.Squalene, green blood, palm oil and tocopherol are mixed in the mixing tank at about 100 RPM for about 30 minutes, and the mixed raw materials are ground in a grinder at 150-200 mesh at about 2500 RPM at a temperature of about 80 ° C, and the ground raw material is mixed into the mixing tank. Transfer, repeat homogeneous grinding and sterilization.
균질분쇄된 원료를 저장탱크로 이송하여 약 100RPM으로 약 2시간 균질화시키며 감압 탈포 시킨 다음 원료를 약 25℃로 낮춘다. 냉각된 원료를 젤라틴(식첨) 76% 및 글리세린(식첨) 24%로 이루어진 캡슐기제로 통상의 방법으로 내용물 450mg되도록 성형, 건조한다.The homogeneously ground raw material is transferred to a storage tank, homogenized at about 100 RPM for about 2 hours, degassed under reduced pressure, and the raw material is lowered to about 25 ° C. The cooled raw material is molded and dried to a content of 450 mg in a conventional manner with a capsule base consisting of 76% gelatin (sliced food) and 24% glycerin (sliced food).
[실시예 2]Example 2
상기 성분을 실시예 1과 같은 방법으로 성형 및 건조시킨다.The components are molded and dried in the same manner as in Example 1.
[실시예 3]Example 3
상기 성분을 실시예 1의 방법으로 성형, 건조하여 연질캡슐을 제조한다.The components are molded and dried by the method of Example 1 to prepare soft capsules.
[실시예 4]Example 4
상기 성분을 실시예 1의 방법으로 성형, 건조시켜서 연질캡슐로 제조한다.The components are molded and dried by the method of Example 1 to prepare soft capsules.
[실시예 5]Example 5
녹혈분말 70%에 인삼가루 10%, 폴렌 5%를 잘 혼합한 다음 꿀 15%에 서서히 가하면서 골고루 혼합하여 환을 제조한 다음 파라핀 왁스로 싸 밀봉하여 제품화 한다.Ginseng powder 10%, pollen 5% and well mixed with 70% of the green blood powder, and then slowly added to 15% honey, evenly mixed to prepare a ring and then wrapped with paraffin wax to be commercialized.
Claims (3)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019910013064A KR940000320B1 (en) | 1990-08-10 | 1991-07-30 | Method of making food containing of nokaren |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR900012290 | 1990-08-10 | ||
| KR90-12290 | 1990-08-10 | ||
| KR1019910013064A KR940000320B1 (en) | 1990-08-10 | 1991-07-30 | Method of making food containing of nokaren |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR920003872A KR920003872A (en) | 1992-03-27 |
| KR940000320B1 true KR940000320B1 (en) | 1994-01-17 |
Family
ID=67386408
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019910013064A KR940000320B1 (en) | 1990-08-10 | 1991-07-30 | Method of making food containing of nokaren |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR940000320B1 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105146544A (en) * | 2015-10-14 | 2015-12-16 | 中国科学院兰州化学物理研究所 | Deer blood polypeptide soft capsule and preparation method thereof |
-
1991
- 1991-07-30 KR KR1019910013064A patent/KR940000320B1/en not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105146544A (en) * | 2015-10-14 | 2015-12-16 | 中国科学院兰州化学物理研究所 | Deer blood polypeptide soft capsule and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| KR920003872A (en) | 1992-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6652891B2 (en) | Co-enzyme Q10 dietary supplement | |
| CN109329907A (en) | A kind of nutritional meal replacement powder and preparation method thereof | |
| US20020146471A1 (en) | Method and composition for improving sexual fitness | |
| CA2228049C (en) | Two-phase preparation | |
| JPH10508313A (en) | Synthetic formulation that promotes hair growth and, optionally, skin and nail growth, and prevents or inhibits hair loss | |
| TW200843726A (en) | Agent for relief or prevention of xerostomia | |
| CN108420854B (en) | Antifatigue composition for improving endurance performance | |
| CN107242527B (en) | Preparation method of edible rose sauce suitable for middle-aged and elderly people | |
| CN106061479B (en) | Weak prophylactic | |
| CN102512655A (en) | L-carnitine composition, L-carnitine preparation and preparation method and application thereof | |
| US20050014825A1 (en) | Preparation and use of solidified oils | |
| CN1080543C (en) | Ginseng processing method and processed ginseng prepared by the same | |
| JPH07147938A (en) | Health food containing powder prepared from deer blood and method for production thereof | |
| CN110353046A (en) | A kind of milk protein solid beverage and its preparation process | |
| KR940000320B1 (en) | Method of making food containing of nokaren | |
| CN101574145B (en) | Nutritional reinforced supplement | |
| US20020098172A1 (en) | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing | |
| KR0180453B1 (en) | Composition for diet | |
| KR101266889B1 (en) | Functional food compositions having the recovery effect of blood composition and function | |
| Kakkar et al. | How Can Flaxseed be Utilized as Functional Food | |
| US7371415B1 (en) | Method and composition for improving sexual fitness | |
| JP6167357B1 (en) | Diabetes mellitus improvement preventive | |
| KR20110136938A (en) | Pill with sea cucumber and manufacturing process thereof | |
| JPH07135923A (en) | Composition for functional food | |
| JP6884302B2 (en) | A composition for preventing fatigue, which comprises black garlic and miso having a Na content of 2.0 wt% or less. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| G160 | Decision to publish patent application | ||
| O035 | Opposition [patent]: request for opposition | ||
| O035 | Opposition [patent]: request for opposition | ||
| O035 | Opposition [patent]: request for opposition | ||
| E601 | Decision to refuse application | ||
| O063 | Decision on refusal after opposition [patent]: decision to refuse application | ||
| J2X1 | Appeal (before the patent court) |
Free format text: APPEAL AGAINST DECISION TO DECLINE REFUSAL Free format text: TRIAL NUMBER: 1995201000237; APPEAL AGAINST DECISION TO DECLINE REFUSAL |
|
| E701 | Decision to grant or registration of patent right | ||
| O073 | Decision to grant registration after opposition [patent]: decision to grant registration | ||
| GRNT | Written decision to grant | ||
| LAPS | Lapse due to unpaid annual fee |